Impact of Poultry Immunosuppressive Diseases on Avian Influenza Antibody Levels
Publish time:2025-06-20 Author:Hao Jianyong Column:Tech Features
Avian Influenza (AI), caused by type A influenza viruses, is a highly contagious disease in poultry that poses a significant threat to the global poultry industry and public health security. Vaccination remains one of the core strategies for AI prevention and control, but its effectiveness is closely linked to the immune status of birds. In recent years, the prevalence of immunosuppressive diseases in poultry has significantly compromised the immune efficacy of AI vaccines, leading to decreased antibody levels, shortened protection periods, and even vaccine failure. This article systematically analyzes the impact of immunosuppressive diseases on AI antibody levels based on their pathogenic mechanisms and proposes scientific prevention and control recommendations.
Overview of Immunosuppressive Diseases
Immunosuppressive diseases are a category of illnesses that disrupt immune response functions by damaging the immune system, leading to reduced disease resistance. Common pathogens causing immunosuppression in poultry include Infectious Bursal Disease Virus (IBDV), Marek's Disease Virus (MDV), Chicken Infectious Anemia Virus (CIAV), Avian Leukosis Virus (ALV), Reovirus (REOV), and Fowl Adenovirus (FADV).
Mechanisms of Immunosuppressive Diseases Affecting AI Antibody Levels
Immunosuppressive diseases primarily impact vaccine-induced antibody levels by destroying immune cell functions, interfering with signaling pathways, and suppressing vaccine responses.
01. Damage to Immune Organs and Suppression of B-Cell Function
Immunosuppressive pathogens (e.g., MDV, IBDV) target immune organs such as the bursa of Fabricius and thymus, causing massive lymphocyte death. These viruses directly destroy B cells or interfere with the function of antigen-presenting cells (e.g., dendritic cells), thereby suppressing the immunogenicity of vaccines. For instance, bursal damage reduces B-cell differentiation, directly affecting antibody production.
Pathogens such as avian influenza viruses can induce the proliferation of regulatory T cells and myeloid-derived suppressor cells. These cells secrete inhibitory factors like TGF-β and IL-10, suppressing the activity of effector T cells and B cells and hindering antibody production. Additionally, chronic immunosuppression reduces the numbers of memory B cells and T cells. When avian influenza viruses mutate, the immune system fails to rapidly recognize and produce high-affinity antibodies, resulting in diminished protection.
02. Interference with Immune Signaling Pathways
Immunosuppressive diseases disrupt key signaling pathways such as JAK/STAT and NF-κB, reducing the expression of antiviral genes and leading to decreased antibody production. For example, avian influenza viruses inhibit the secretion of IL-12 and IFN-γ, weakening Th1-type immune responses and impairing the differentiation of B cells into plasma cells.
03. Vicious Cycle of Immunosuppression and Co-infections
Immunosuppressive diseases often co-infect with other pathogens (e.g., bacteria, viruses, fungi), exacerbating immune suppression. For instance, chickens infected with REV and simultaneously exposed to avian influenza exhibit a greater decline in antibody levels compared to single infections. ALV infection impairs macrophage function, facilitating avian influenza virus replication in the respiratory tract and secondary E. coli infections, further burdening the immune system. This vicious cycle sustains low antibody levels and significantly increases mortality.
Summary and Prevention Recommendations
Immunosuppressive diseases severely impair poultry antibody responses to vaccines by damaging immune organs, suppressing cellular functions, and triggering co-infections. This not only leads to individual vaccine failure but may also cause group outbreaks and increase the risk of viral mutations.
Prevention and control measures should include:
- Strengthening Biosecurity: Adhere to self-reproduction and all-in-all-out systems, with regular disinfection.
- Optimizing Feeding Management: Supplement vitamins, trace elements, and anti-stress medications (e.g., electrolyte multivitamins).
- Scientific Vaccination: Use high-quality vaccines, develop scientifically sound immunization programs, and enhance antibody monitoring.
- Breeding Source Purification: Dynamically monitor pathogens and antibodies, cull positive individuals, and select disease-resistant breeds.
A multi-faceted collaborative approach is essential to reduce the risk of immunosuppression and safeguard farming profitability.
